Effects of oxidized low density lipoprotein on endothelin secretion by cultured endothelial cells and macrophages

Atherosclerosis

Volumn 119, Issue 1, 1996, Pages 107-118

  He, Yi ^a   Kwan, W C Peter ^a   Steinbrecher, Urs P ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Atherosclerosis; Endothelial cells; Endothelin; Macrophages; Oxidized LDL

Indexed keywords

ENDOTHELIN 1; LOW DENSITY LIPOPROTEIN;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CONTROLLED STUDY; ENDOTHELIUM; HUMAN; HUMAN CELL; MACROPHAGE; MONOCYTE; PRIORITY JOURNAL;

EID: 0030051701     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/0021-9150(95)05636-X     Document Type: Article

References (50)

1. Haberland M, Fong D, Cheng L. Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits. Science 1988;24:215.
2. Palinski W, Rosenfeld ME, Ylä-Herttuala S, Gurtner GC Socher SS, Butler SW, Parthasarathy S, Carew TE, Steinberg D Witztum JL. Low density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci USA 1989;86:1372.
3. Rosenfeld ME, Palinski W, Ylä-Herttuala S, Butler S Witztum JL. Distribution of oxidation specific lipid-protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from WHHL rabbits. Arteriosclerosis 1990;10:336.
4. Ylä-Herttuala S, Palinski W, Rosenfeld ME Parthasarathy S, Carew TE, Butler S, Witztum JL, Steinberg D. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest 1989;84:1086.
5. Carew TE, Schwenke DC, Steinberg D. Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. Proc Natl Acad Sci USA 1987;84:7725.
6. Kita T, Nagano Y, Yokode M, Ishii K, Kume N, Ooshima A Yoshida H, Kawai C. Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia. Proc Natl Acad Sci USA 1987;84:5928.
7. Daugherty A, Zweifel BS, Schonfeld G. Probucol attenuates the development of atherosclerosis in cholesterol-fed rabbits. Br J Pharmacol 1989;98:612.
8. Björkhem I, Henriksson FA, Breuer O, Diczfalusy U Berglund L, Henriksson P. The antioxidant butylated hydroxytoluene protects against atherosclerosis. Arterioscler Thromb 1991;11:15.
9. Sparrow CP, Doebber TW, Olszewski J, Wu MS, Ventre J Stevens KA, Chao Y-S. Low density lipoprotein is protected from oxidation and the progression of atherosclerosis is slowed in cholesterol-fed rabbits by the antioxidant N,N′-diphenyl-phenylenediamine. J Clin Invest 1992;89:1885.
10. Steinberg D, Parthasarathy S, Carew TE, Khoo JC Witztum JL. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989;320:915.
11. Kugiyama K, Kerns SA, Morrisett JD, Roberts R Henry PD. Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature 1990;344:160.
12. Mangin EJ, Kugiyama K, Nguy JH, Kerns SA, Henry PD. Effects of lysolipids and oxidatively modified low density lipoprotein on endothelium-dependent relaxation of rabbit aorta. Circ Res 1993;72:161.
13. Galle J, Mülsch A, Busse R, Bassenge E. Effects of native and oxidized low density lipoproteins on formation and inactivation of endothelium-derived relaxing factor. Arteriosclerosis 1991;11:198.
14. Galle J, Lückhoff A, Busse R, Bassenge E. Low-density lipoproteins stimulate internal free calcium and prostacyclin release in endothelial cells. Eicosanoids 1990;3:81.
15. Jacobs M, Plane F, Bruckdorfer KR. Native and oxidized low-density lipoproteins have different inhibitory effects on endothelium-derived relaxing factor in the rabbit aorta. Br J Pharmacol 1990;100:21.
16. Brown KD, Littlewood CJ. Endothelin stimulates DNA synthesis in Swiss 3T3 cells: synergy with polypeptide growth factors. Biochem J 1989;263:977.
17. Dubin D, Pratt RE, Cooke JP, Dzau VJ. Endothelin, a potent vasoconstrictor, is a vascular smooth muscle mitogen. J Vasc Med Biol 1989;1:150.
18. Muldoon LL, Pribnow D, Rodland KD, Magun BE. Endothelin-1 stimulates DNA synthesis and anchorage-independent growth of rat-1 fibroblasts through a protein kinase-C dependent mechanism. Cell Regul 1990;1:379.
19. Takuwa N, Takuwa Y, Yanagisawa M, Kudo M, Masaki T. A novel vasoactive peptide endothelin stimulates mitogenesis through inostol lipid turnover in Swiss 3T3 fibroblasts. J Biol Chem 1989;264:7856.
20. Bobik A, Grooms A, Millar JA, Milchell A, Grinpulel S. Growth factor activity of endothelin on vascular smooth muscle. Am J Physiol 1990;258:C408.
21. Komuro I, Kurihara H, Sugiyama T, Takaku F, Yazaki Y. Endothelin stimulates c-fos and c-myc expression and proliferation of vascular smooth muscle cells. FEBS Lett 1988;238:249.
22. Hiroe M, Hirata Y, Marumo F, Nagata M, Toyozaki T Hasumi M, Ohta Y, Horie T, Sekiguchi M. Immunohistochemical localization of endothelin in human vascular endothelial cells. Peptide 1989;10:1281.
23. Howard PG, Plumpton C, Davenport AP. Anatomical localization and pharmacological activity of mature endothelins and their precursors in human vascular tissue. J Hypertens 1992;10:1379.
24. Miyauchi T, Tomobe Y, Shiba R, Ishikawa TMY, Kimura S Sujishita Y, Ito I, Goto K, Masaki T. Involvement of endothelin in the regulation of human vascular tonus. Potent vasoconstrictor effect and existence in endothelial cells. Circulation 1990;81:1874.
25. Winkles A, Alberts G, Brogi E, Libby P. Endothelin-1 and endothelin receptor mRNA expression in normal and atherosclerotic human arteries. Biochem Biophys Res Commun 1993;191:1081.
26. Boulanger CM, Tanner FC, Bea ML, Hahn AW, Werner A Lüscher TF. Oxidized low density lipoproteins induce mRNA expression and release of endothelin from human and porcine endothelium. Circ Res 1992;70:1191.
27. Horio T, Kohno M, Yasunari K, Murakawa K, Yokokawa K Ikedaka M, Fukui T, Takeda T. Stimulation of endothelin-1 release by low density and very low density lipoproteins in cultured human endothelial cells. Atherosclerosis 1993;101:185.
28. Jougasaki M, Kugiyama K, Saito Y, Nakao K, Imura H Yasue H. Suppression of endothelin-1 secretion by lysophosphatidylcholine in oxidized low density lipoprotein in cultured vascular endothelial cells. Circ Res 1992;71:614.
29. Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 1955;43:1345.
30. Bilheimer DW, Eisenberg S, Levy RI. The metabolism of very low density lipoproteins. Biochim Biophys Acta 1972;260:212.
31. Goldstein JL, Ho YK, Basu SK, Brown MS. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci USA 1979;76:333.
32. Gimbrone MA, Cotran RS, Folkman J. Human vascular endothelial cells in culture. J Cell Biol 1974;60:673.
33. Steinbrecher UP, Parthasarathy S, Leake DS, Witztum JL Steinberg D. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc Natl Acad Sci USA 1984;81:3883.
34. Steinbrecher UP, Witztum JL, Parthasarathy S Steinberg D. Decrease in reactive amino groups during oxidation or endothelial cell modification of LDL. Correlation with changes in receptor-mediated catabolism. Arteriosclerosis 1987;7:135.
35. Steinbrecher UP. Oxidation of human low density lipoproteins results in derivatization of lysine residues of apolipoprotein B by lipid peroxide decomposition products. J Biol Chem 1987;262:3603.
36. Berliner JA, Territo MC, Sevanian A, Ramin S, Kim JA Bamshad B, Esterson M, Fogelman AM. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J Clin Invest 1990;85:1260.
37. Ehrenreich H, Anderson R, Fox C, Rieckman P, Hoffman G, Travis W, Coligan J, Kehrl J, Fauci A, Endothelins, peptides with potent vasoactive properties, are produced by human macrophages. J Exp Med 1990;172:1741.
38. Sugiura M, Inagami T, Kon V. Endotoxin stimulates endothelin-release in vivo and in vitro as determined by radioimmunoassay. Biochem Biophys Res Commun 1989;161:1220.
39. Hessler JR, Morel DW, Lewis LJ, Chisolm GM. Lipoprotein oxidation and lipoprotein-induced cytotoxicity. Arteriosclerosis 1983;3:215.
40. Kosugi K, Morel DW, DiCorleto PE, Chisolm GM. Toxicity of oxidized low density lipoprotein to cultured fibroblasts is selective for the S phase of the cell cycle. J Cell Physiol 1987;102:119.
41. Steinbrecher UP, Pritchard PH. Hydrolysis of phosphatidylcholine during LDL oxidation is mediated by platelet-activating factor acetylhydrolase. J Lipid Res 1989;30:305.
42. Stremler KE, Stafforini DM, Prescott SM, Zimmerman SM McIntyre TM. An oxidized derivative of phosphatidylcholine is a substrate for the platelet-activating factor acetylhydrolase from human plasma. J Biol Chem 1989;264:5331.
43. Stremler K, Stafforini D, Prescott S, McIntyre T. Human plasma platelet-activating factor acetylhydrolase. Oxidatively fragmented phospholipids as substrates. J Biol Chem 1991;266:11095.
44. Liapikos T, Antonopoulou S, Karabina S, Tsoukatos D Demopoulos C, Tselepis A. Platelet-activating factor formation during oxidative modification of low-density lipoprotein when PAF-acetylhydrolase has been inactivated. Biochim Biophys Acta 1994;1212:353.
45. Parthasarathy S, Barnett J. Phospholipase A2 activity of low density lipoprotein: evidence for an intrinsic phospholipase A2 activity of apoprotein B-100. Proc Natl Acad Sci USA 1990;87:9741.
46. Yanagisawa M, Inoue A, Takuwa Y, Mitsui Y, Kobayashi M Masaki T. The human preproendothelin-1 gene: possible regulation by endothelial phosphoinositide turnover signaling. J Cardiovasc Pharmacol 1989;13:513.
47. Zhang H, Davis WB, Chen W, Jones KH, Whisler RL Cornwell DG. Effects of oxidized low density lipoproteins on arachidonic acid metabolism in smooth muscle cells. J Lipid Res 1990;31:551.
48. Moog C, Deloulme JC, Baudier J, Revel MO, Bischoff P Hietter H, Luu B. Membrane-related oxysterol function: preliminary results on the modification of protein kinase C activity and substrate phosphorylation by 7B 25-dihydroxycholesterol. Biochimie 1991;73:1321.
49. Martin-Nizard F, Houssaini HS, Lestavel-Delattre S Duriez P, Fruchart JC. Modified low density lipoproteins activate human macrophages to secrete immunoreactive endothelin. FEBS Lett 1991;293:127.
50. Esterbauer H, Gebicki J, Puhl H, Jurgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic Biol Med 1992;13:341.